Share this article
Share this article
SHENZHEN, China, March 16, 2021 /PRNewswire/ EDAN Instruments, Inc. ( EDAN or the Company) (SHE: 300206) on Monday announced its results for the preceding fiscal year (FY 2020) with revenue of CNY 2.3 billion. The company also revealed its strategic 5+1 plan and its anticipation for 2025.
EDAN s 2020 Financial Highlights (all results compared to FY 2019)
Revenues increased 104.1% to CNY 2.3 billion, in which CNY 1.4 billion are from Patient Monitoring products with a 270.65% increment compared to FY 2019
Net profit attributed to shareholders reached CNY 653 million vs. CNY 131.3 million
Operating income increased 447% to CNY 745 million
Net cash from operating activities increased 498% to CNY 689 million
A new lightweight AI-powered robotic glove pioneered by a Scottish biotech start-up, BioLiberty, could help deliver independence to millions of people with reduced mobility.